CD4 and COVID-19: Taken together with existing data10,33–35, our results indicate that adults with HIV receiving suppressive antiretroviral therapy and who have CD4+ T-cell counts in the healthy range, mount broadly comparable “peak” humoral immune responses to two COVID-19 vaccine doses compared to individuals without HIV.